Key facts
- This page summarizes Jaye Thompson's Form 4 filing for Greenwich LifeSciences, Inc. (GLSI).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 25 Nov 2024, 06:03.
Jaye Thompson - 21 Nov 2024 Form 4 Insider Report for Greenwich LifeSciences, Inc. (GLSI)
- Reporting relationship
- VP Clinical Reg Affairs
- Issuer ticker
- GLSI
- Reported as of
- 21 Nov 2024
- Net transaction value
- +$12,910
- SEC form
- 4
- Accepted by SEC
- 25 Nov 2024, 06:03:54 UTC
- Prior SEC filing
- 16 Sep 2024
- Next SEC filing
- 27 Dec 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jaye Thompson
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jaye Thompson filed Form 4 for Greenwich LifeSciences, Inc. (GLSI) on 25 Nov 2024.
Change
- Previous filing in this sequence was filed on 16 Sep 2024.
- Current net transaction value: +$12,910.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GLSI
transaction
Common Stock
Purchase
- Transaction value
- $12,910
- Shares
- +1,000
- Change %
- +0.38%
- Price
- $12.91
- Shares after
- 264,148
- Date
- 21 Nov 2024
- Ownership
- Direct
* marks a reported price that did not pass the local price check.